Aytu BioPharma, Inc. (AYTU) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Aytu BioPharma, Inc. (AYTU) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $18.0M, listed on NASDAQ, employing roughly 83 people, carrying a beta of 0.25 to the broader market. Aytu BioPharma, Inc. Led by Joshua R. Disbrow, public since 2008-09-25.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for AYTU as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →